dc.creatorUsach, Vanina
dc.creatorCoronel, Maria Florencia
dc.creatorMalet, Mariana
dc.creatorPiñero, Gonzalo Miguel
dc.creatorLeiguarda, Candelaria
dc.creatorCasadei, Inelia Mailín Iara
dc.creatorVillar, Marcelo Jose
dc.creatorSetton, Clara Patricia
dc.creatorBrumovsky, Pablo Rodolfo
dc.date.accessioned2020-04-20T17:35:05Z
dc.date.accessioned2022-10-15T04:56:53Z
dc.date.available2020-04-20T17:35:05Z
dc.date.available2022-10-15T04:56:53Z
dc.date.created2020-04-20T17:35:05Z
dc.date.issued2018-05
dc.identifierUsach, Vanina; Coronel, Maria Florencia; Malet, Mariana; Piñero, Gonzalo Miguel; Leiguarda, Candelaria; et al.; Bone Marrow-Derived Cells and Peripheral Nerve Injury: Translational Implications for Pain and Regeneration Treatments; All Published; Clinical Pharmacology and Translational Medicine; 2; 5-2018; 112-124
dc.identifier2572-7656
dc.identifierhttp://hdl.handle.net/11336/103065
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4347254
dc.description.abstractTraumatic injury of peripheral nerves is a serious concern for both patients and clinicians, and is commonly associated to neuropathicpain and complete or partial loss of functionality of the affected limb. Stem cell therapy has emerged as a promising tool to improvethe outcome of patients with peripheral nerve injury, and an increasing number of pre-clinical and clinical studies are adding supporttowards their use in humans. In the present review, we will address specifically the participation of bone marrow stromal cells (BMSC;including a group of multipotent adult progenitor cells (MAP)) and bone marrow mononuclear cells (BMMC, a heterogeneousfraction that contains BMSC populations, among others), both of endogenous origin or exogenously transplanted, for the control ofpain and the improvement of regeneration. We will describe the state-of-the-art knowledge on the cellular and molecularmechanisms involved in the action of BMSC and BMMC during traumatic injury of nerves. Finally, we will address the translationalimplications that may eventually lead to therapeutic options for humans.
dc.languageeng
dc.publisherAll Published
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://applispublishers.com/clinical-pharmacology-and-translational-medicine-cptm-archive/
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAllodynia
dc.subjectBone Marrow
dc.subjectHyperalgesia
dc.subjectMesenchymal Stem Cells
dc.subjectNeuropathic Pain
dc.subjectPeripheral Nerve Injury
dc.subjectRegeneration
dc.titleBone Marrow-Derived Cells and Peripheral Nerve Injury: Translational Implications for Pain and Regeneration Treatments
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución